pelvilen
Dual Act

Description
Chronic pelvic pain associated with numerous pelvic disorders (endometriosis, interstitial cystitis, recurrent cystitis, chronic prostatitis, irritable bowel syndrome, etc.) is a dual-localized nosological entity resulting from neuroinflammation caused by non-neuronal cells (mast cells, microglia). Tissue localization, linked to peripheral sensitization of the sensory endings of nerves co-innervating different pelvic organs, determines the extent of diffuse inflammatory pain and associated oxidative stress. Spinal localization, linked to central sensitization arising from chronic peripheral neuroinflammatory disease, determines and sustains the extent of neuropathic pain, which amplifies the pain experienced by the patient.
Pelvilen Dual Act effectively targets both components of pain (mixed pain) through a synergistic and synchronous regulatory effect exerted by palmitoylethanolamide in its two forms, micronized and ultra-micronized. The simultaneous presence of polydatin, a polyphenol with high antioxidant activity, helps control the oxidative stress associated with neuroinflammation in pelvic tissues.

Ingredients
Palmitoylethanolamide-polydatin co-micronized form (particle size 2.0-10.0 microns), ultra-micronized palmitoylethanolamide (particle size 0.8-6.0 microns); emulsifiers: microcrystalline cellulose, magnesium salts of fatty acids, vegetable polysorbate, E1521; stabilizers: croscarmellose sodium, polyvinylpyrrolidone, polyvinylalcohol; anti-caking agents: silicon dioxide, talc; colorants: E132, E171, E172.

Gluten free.

Nutritional characteristics

Average values	per 1 tablet	per 100 g
Energy	7.13 kcal 29.9 kJ	631 kcal 2,642 kJ
Proteins	<0.01 g	<1.0 g
Carbohydrates of which sugars	<0.01 g	<1.0 g
Fats of which saturated	0.79 g 0.68 g	70.0 g 60.0 g
Dietary fiber	0.20 g	17.5 g
Salt	0.014 g	1.25 g
Palmitoylethanolamide	0.800 g	70.8 g
Polydatin	0.040 g	3.54 g

How to use
Pelvilen Dual Act, in its two different formulations (sublingual microgranules and tablets), must be used under medical supervision. It is recommended to take it as follows:
-Pelvilen Dual Act microgranules, preferably taken sublingually, as per medical advice, as a guideline 1-2 sachets per day for cycles of at least 10 days, possibly repeated.
-Pelvilen Dual Act tablets, as per medical advice, as a guideline 1-2 tablets per day for cycles of 20-30 days, possibly repeated.

Warnings
Use under medical supervision.
Products cannot represent the only source of nutrition.
Keep out of reach of children under 3 years.
The use of the products during pregnancy is not recommended.

Conservation
Store at room temperature.
Shelf life in intact packaging : 36 months.

Format
Blister pack of 20 tablets.

Cod. 8026